CA2442437A1 - Agent for the treatment of overactive bladder - Google Patents

Agent for the treatment of overactive bladder Download PDF

Info

Publication number
CA2442437A1
CA2442437A1 CA002442437A CA2442437A CA2442437A1 CA 2442437 A1 CA2442437 A1 CA 2442437A1 CA 002442437 A CA002442437 A CA 002442437A CA 2442437 A CA2442437 A CA 2442437A CA 2442437 A1 CA2442437 A1 CA 2442437A1
Authority
CA
Canada
Prior art keywords
compound
inactivating
slowly
type
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002442437A
Other languages
English (en)
French (fr)
Inventor
Tsuyoshi Yamagata
Kaoru Atsuki
Tetsuji Ohno
Shiro Shirakura
William C. Degroat
Adrian Sculporeanu
Akira Karasawa
Naoki Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
University of Pittsburgh
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2442437A1 publication Critical patent/CA2442437A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002442437A 2001-03-30 2002-03-29 Agent for the treatment of overactive bladder Abandoned CA2442437A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27969801P 2001-03-30 2001-03-30
US60/279,698 2001-03-30
PCT/US2002/009577 WO2002078523A2 (en) 2001-03-30 2002-03-29 Agent for the treatment of overactive bladder

Publications (1)

Publication Number Publication Date
CA2442437A1 true CA2442437A1 (en) 2002-10-10

Family

ID=23070051

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002442437A Abandoned CA2442437A1 (en) 2001-03-30 2002-03-29 Agent for the treatment of overactive bladder

Country Status (4)

Country Link
EP (1) EP1372630A4 (enExample)
JP (1) JP2005506296A (enExample)
CA (1) CA2442437A1 (enExample)
WO (1) WO2002078523A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388898B (en) * 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT979821E (pt) * 1997-04-15 2007-01-31 Kyowa Hakko Kogyo Kk Compostos triciclicos

Also Published As

Publication number Publication date
WO2002078523A3 (en) 2003-07-24
WO2002078523A2 (en) 2002-10-10
EP1372630A2 (en) 2004-01-02
EP1372630A4 (en) 2005-03-23
JP2005506296A (ja) 2005-03-03

Similar Documents

Publication Publication Date Title
DE60121096T2 (de) Methode zur Behandlung von Fettsucht anhand eines Neurotensinreceptor-Liganden
EP1405638B1 (en) Pharmaceutical composition comprising quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinoline-2-carboxylate for treatment of interstitial cystitis and/or abacterial prostatitis
KR102661138B1 (ko) 치글리타자르 및 이의 관련 화합물의 용도
CA2957804C (en) Pharmaceutical composition for prevention and/or treatment of urinary incontinence
US7122173B2 (en) Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
US20040132803A1 (en) Agent for the treatment of overactive bladder
CA2442437A1 (en) Agent for the treatment of overactive bladder
DE60119742T2 (de) Methode zur behandlung der hyperaktiven blase
AU2002258641A1 (en) Agent for the treatment of overactive bladder
US7276532B2 (en) Remedies for vesical hyperactivity
US20040110784A1 (en) Remedies for vesical stimulation association with prostatauxe
HUP0303609A2 (hu) Húgyhólyag-túlérzékenység kezelésére alkalmas készítmény
AU2002338234A1 (en) Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
JPH02250828A (ja) 新規免疫抑制剤
CN111253318A (zh) 一种替米沙坦衍生物及其用途
HK1064620A (en) Remedies for vesical hyperesthesia

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead